Skip to main content

Bovine Lactoferrin Market Size [2021-2028] worth USD 1,461.3 Million | exhibiting a CAGR of 12.6%

Written by Customer Service on . Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global Bovine Lactoferrin Market size is projected to reach USD 1,461.3 Million in 2028, at CAGR of 12.6% during forecast period; Increasing Applications in Food, Dietary Supplements, and Pharmaceutical to Aid Growth: Fortune Business Insights™

Pune, India, June 21, 2022 (GLOBE NEWSWIRE) — The Global Bovine Lactoferrin Market Size is set to gain traction from its rising applications in pharmaceutical, food & beverage, and dietary supplements. Nowadays, the general population is highly demanding for naturally derived supplements, rather than the ones containing chemical molecules. It is set to propel the demand for bovine lactoferrin across the globe. As per a report by Fortune Business Insights™, titled, “Bovine Lactoferrin Market, 2021-2028,” the market size stood at USD 601.1 million in 2020. It is projected to grow from USD 635.3 million in 2021 to USD 1,461.3 million in 2028 at a CAGR of 12.6% in 2021-2028.

Key Industry Development

June 2021: Beston Global Food added two lactoferrin extraction columns in its Jervois plant, South Australia. It would enable the company to manufacture approximately 5% of the world’s demand for lactoferrin at present.

January 2021: Bega Cheese Limited acquired Lion Dairy & Drinks, a Kirin-owned food company. The deal is worth USD 334 million and it would allow the company to broaden its portfolio range with yogurt, juice, and milk brands.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/bovine-lactoferrin-market-101656


Report Scope:

Report Coverage Details
Forecast Period 2021 to 2028
Forecast Period 2021 to 2028 CAGR 12.6%
2028 Value Projection USD 1,461.3 million
Base Year 2020
Market Size in 2021 USD 635.3 million
Historical Data for 2017 to 2019
No. of Pages 192


Market Growth Drivers

Surging Development of Affordable Production Technology to Boost Growth

Various technology oriented companies are currently striving persistently to launch cost-effective methods to produce bovine lactoferrin. Conagen, Inc., for instance, created an affordable process to manufacture this ingredient in April 2020 by utilizing microbial fermentation technology. However, several private and governmental agencies are encouraging people to practice breastfeeding, which, in turn, is set to lower the demand for infant formula, thereby restraining the bovine lactoferrin market growth in the near future.

Report Coverage

Our analysts have conducted qualitative and quantitative research, as well as a mixture of primary and secondary resources to gather information about the market. They have taken data from press releases, paid databases, company journals, and other sources to offer a complete picture of the market. To collect information about the competitive landscape they have conducted interviews with renowned personalities.

Click here to get the short-term and long-term impact of COVID-19 on this Market:

https://www.fortunebusinessinsights.com/industry-reports/bovine-lactoferrin-market-101656


Market Segmentations:

Dietary Supplements & Food Segment to Register High CAGR Backed by Awareness of Health

By applications, the Bovine Lactoferrin Market is segregated into infant formula, pharmaceuticals, dietary supplements, food, and others. Out of these, the dietary supplements and food segments are anticipated to showcase significant CAGR in the near future because of the higher awareness about immunity and health among common people.

         Segmentation By Product

  • Freeze-dried
  • Spray-dried
By Application

  • Infant Formula
  • Dietary Supplements
  • Pharmaceuticals
  • Food
  • Others
By Geography

  • North America (U.S., Canada)
  • Europe (U.K., France, Italy, Spain, Germany, Scandinavia, and Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)

 


Regional Insights

North America Held USD 95.6 Million Revenue in 2020

Geographically, North America held USD 95.6 million in terms of revenue in 2020. This growth is attributable to the rising number of clinical trials conducted by numerous U.S.-based pharmaceutical companies to find novel applications of bovine lactoferrin, especially in the healthcare sector. On the other hand, Europe is likely to show a significant share backed by the surging demand for bovine lactoferrin-infused dietary supplements and infant formula.

Competitive Landscape

Key Players Focus on Expansion and Acquisition Strategies to Strengthen Their Positions

The global market houses several reputed companies and is semi-consolidated. Most of them are focusing on acquisition and production capacity expansions to strengthen their positions in this market. A few others are aiming to introduce new products infused with the unique ingredient for a large number of applications.

Quick Buy – Bovine Lactoferrin Market:

https://www.fortunebusinessinsights.com/checkout-page/101656


The Report Lists the Key Companies in the Global Bovine Lactoferrin Market

  • MILEI GmbH (Allgäu, Germany)
  • FrieslandCampina DOMO (Amersfoort, Netherlands)
  • Synlait Ltd. (Canterbury, New Zealand)
  • Glanbia Plc. (Kilkenny, Ireland)
  • Bega Bionutrients (Melbourne, Australia)
  • Saputo Dairy Australia Pty Ltd. (Victoria, Australia)
  • Fonterra Co-operative Group (Auckland City, New Zealand)
  • FREEDOM FOODS GROUP LIMITED (Caringbah, Australia)
  • Beston Global Food Company Ltd (Adelaide, Australia)
  • Armor Protéines (Saint-Brice-en-Coglès, France)
  • Ingredia (Arras, France)

Table of Contents

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Technological Advancements
    • Regulatory Scenario – For Key Countries
    • Pricing Analysis
    • Impact of COVID-19 on the Global Bovine Lactoferrin Market
    • Overview of Lactoferrin Description, Claim, Content on Packages
  • Global Bovine Lactoferrin Market Analysis, Insights and Forecast, 2017-2028 
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Freeze Dried and Milled
      • Spray Dried Powder
    • Market Analysis, Insights and Forecast – By Application
      • Infant Formula
      • Dietary Supplements
      • Pharmaceutical
      • Food
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Bovine Lactoferrin Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Freeze Dried and Milled
      • Spray Dried Powder
    • Market Analysis, Insights and Forecast – By Application
      • Infant Formula
      • Dietary Supplements
      • Pharmaceutical
      • Food
      • Others
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
      • Canada
  • Europe Bovine Lactoferrin Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Freeze Dried and Milled
      • Spray Dried Powder
    • Market Analysis, Insights and Forecast – By Application
      • Infant Formula
      • Dietary Supplements
      • Pharmaceutical
      • Food
      • Others
    • Market Analysis, Insights and Forecast – By Country/ Sub-region
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Scandinavia
      • Rest of Europe
  • Asia Pacific Bovine Lactoferrin Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Freeze Dried and Milled
      • Spray Dried Powder
    • Market Analysis, Insights and Forecast – By Application
      • Infant Formula
      • Dietary Supplements
      • Pharmaceutical
      • Food
      • Others
    • Market Analysis, Insights and Forecast – By Country/ Sub-region
      • Japan
      • China
      • India
      • Australia
      • Southeast Asia
      • Rest of APAC

ToC Continued…


Have Any Query? Ask Our Experts:

 https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/bovine-lactoferrin-market-101656


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com


Press Release: https://www.fortunebusinessinsights.com/press-release/bovine-lactoferrin-market-9357

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.